Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients

Journal of Vascular Access

Volumn 13, Issue 2, 2012, Pages 168-174

  Wasse, Haimanot ^a   Huang, Rong ^a   Naqvi, Nawazish ^b   Smith, Eileen ^c   Wang, Dezhi ^d   Husain, Ahsan ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AVF; CKD; Dialysis access; Inflammation; Oxidation

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL REPLACEMENT THERAPY; VASCULAR ACCESS;

EID: 84866549697     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000024     Document Type: Article

References (15)

1. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164-2171.
2. Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782-790.
3. Roy-Chaudhury P, Kelly BS, Miller MA, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59:2325-2334.
4. Budu-Grajdeanu P, Schugart RC, Friedman A, Valentine C, Agarwal AK, Rovin BH. A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model. 2008;5:2.
5. Krueger U, Zanow J, Scholz H. Computational fluid dynamics and vascular access. Artif Organs. 2002;26:571-575.
6. Ene-Iordache B, Mosconi L, Remuzzi G, Remuzzi A. Computational fluid dynamics of a vascular access case for hemodialysis. J Biomech Eng. 2001;123:284-292.
7. Yevzlin AS, Conley EL, Sanchez RJ, Young HN, Becker BN. Vascular access outcomes and medication use: a USRDS study. Semin Dial. 2006;19:535-539.
8. Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43:74-84.
9. Lee T, Chauhan V, Krishnamoorthy M, et al. Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant. 2011;26:2264-2270.
10. Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis. 2006;48:S176-S273.
11. Marrone D, Pertosa G, Simone S, et al. Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. Am J Kidney Dis. 2007;49:664-673.
12. Stracke S, Konner K, Kostlin I, et al. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int. 2002;61:1011-1019.
13. Weiss MF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis. 2001;37:970-980.
14. Vindis C, Escargueil-Blanc I, Uchida K, Elbaz M, Salvayre R, Negre-Salvayre A. Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis. Redox Rep. 2007;12:96-100.
15. Lim S, Moon MK, Shin H, et al. Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats. Cardiovasc Res. Feb 4 2011.